Tukaram Mundhe, the Commissioner for Maharashtra's Food and Drug Administration, is worried about the huge price differences in hospital medical devices. For example, a Medifusion IV set that costs Rs 11.05 is sold for Rs 325, marking a 2,841% markup. His team also noticed big price gaps in items like catheters and syringes. Mundhe has asked the Department of Pharmaceuticals and the National Pharmaceutical Pricing Authority to step in and suggested better regulations to lessen costs for patients.Why Hospital Device Prices Face ReviewThe Maharashtra FDA survey has highlighted a major difference between procurement costs and prices shown for some hospital consumables. An IV infusion set purchased for Rs 11.05 was listed at Rs 325, while a catheter bought for Rs 29.41 had an MRP of Rs 310.Mundhe said such gaps require examination and called for a review of the existing pricing framework for medical devices used in hospitals.The Medifusion IV set had a reported 2,841% markup.A catheter purchased for Rs 29.41 had an MRP of Rs 310.An autofusion set costing Rs 70 had an MRP of Rs 393.A 10 ml syringe purchased for Rs 6.75 had an MRP of Rs 57.20.Nebulisers and oxygen masks costing Rs 40–45 were reported at Rs 650–715.Maharashtra Survey Finds Wide GapsThe Maharashtra FDA looked into hospital supplies and found big price differences for items like syringes, nebulizers, and oxygen masks. They compared buying prices to what patients pay, but this doesn’t mean all hospitals charge the same. This raises concerns about how prices are set as products move from makers to hospitals. Mundhe believes pricing is a key health issue since patients may pay more because of these differences. He wants a wider policy review instead of just checking single transactions.Also Read: Maharashtra FDA Makes Food Safety Rules Mandatory For Every Ganesh MandalMundhe Seeks National Pricing ReviewMundhe has contacted the Department of Pharmaceuticals and the NPPA about their findings. He suggests including hospital devices and supplies in the pricing rules and looking into whether price margins need to be adjusted or specific items should be monitored more closely. The NPPA is already reviewing device prices and has heard similar requests from other states.Key HighlightsMaharashtra FDA flagged medical-device price gaps of up to 2,841%.An IV set costing Rs 11.05 had an MRP of Rs 325.A catheter bought for Rs 29.41 had an MRP of Rs 310.Mundhe has sought a review from the NPPA and Department of Pharmaceuticals.The proposal includes examining trade-margin controls for essential hospital consumables.The move aims to improve pricing transparency and protect patients from excessive costs.ConclusionThe Maharashtra FDA's survey has focused new attention on the prices of medical devices and hospital supplies in India. For example, the IV-set price difference of Rs 11.05 compared to Rs 325 stands out. Commissioner Tukaram Mundhe has asked for a review that could spark talks about pricing and trade margins for essential medical devices. Any decision will depend on further checks by the relevant authorities.Disclaimer: This article is intended only for knowledge purposes and to provide news information based on publicly available reports. Reported price gaps should not be treated as proof of wrongdoing unless established by the competent authorities.
